Abstract
Cancer heterogeneity, long recognized as an important clinical determinant of patient outcomes, was poorly understood at a molecular level. Genomic studies have significantly improved our understanding of heterogeneity, and have pointed to ways in which heterogeneity might be understood and defeated for therapeutic effect. Recent studies have evaluated intratumoral heterogeneity within the primary tumor, as well as heterogeneity observed between primary and metastasis. The existence of clonal heterogeneity in the primary and metastasis also affects response to therapy, since the Darwinian pressures of systemic therapy result in clonal selection for initially rare variants. Novel technologies (such as measurements of circulating tumor cells and circulating tumor DNA) may allow physicians to monitor the emergence of clonal subtypes and intervene at an early point to improve patient prognosis.
Keywords
Genetic heterogeneityTumor heterogeneitySomatic evolution in cancerMetastasisCancerPrimary tumorTumour heterogeneityCirculating tumor cellBiologyPhenotypeGeneticsGene
Related Publications
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis and a lack of effective therapeutic options. Accumulating evidence suggests tha...
Quantitative Imaging in Cancer Evolution and Ecology
Cancer therapy, even when highly targeted, typically fails because of the remarkable capacity of malignant cells to evolve effective adaptations. These evolutionary dynamics are...
Network-based stratification of tumor mutations
Many forms of cancer have multiple subtypes with different causes and clinical outcomes. Somatic tumor genome sequences provide a rich new source of data for uncovering these su...
Breast Cancer Treatment
Breast cancer consists of 3 major tumor subtypes categorized according to estrogen or progesterone receptor expression and ERBB2 gene amplification. The 3 subtypes have distinct...
Tumor microenvironment complexity and therapeutic implications at a glance
The dynamic interactions of cancer cells with their microenvironment consisting of stromal cells (cellular part) and extracellular matrix (ECM) components (non-cellular) is esse...
Publication Info
- Year
- 2014
- Type
- article
- Volume
- 28
- Issue
- 9
- Pages
- 772-8
- Citations
- 112
- Access
- Closed
External Links
Citation Metrics
112
OpenAlex
Cite This
Kimberly H. Allison,
George W. Sledge
(2014).
Heterogeneity and cancer..
PubMed
, 28
(9)
, 772-8.